Stock AGH ALTHEA GROUP HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Althea Group Holdings Limited

Equities

AGH

AU0000022774

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 02:10:11 2024-05-03 am EDT 		5-day change 1st Jan Change
0.03 AUD +3.45% Intraday chart for Althea Group Holdings Limited 0.00% -23.08%
Apr. 30 Althea Group Holdings Posts AU$8 Million in Cash Receipts in Fiscal Q3 MT
Apr. 22 Althea Group Signs Distribution Agreement with Symbion MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023
Capitalization 1 205.3 74.66 80.02 18.64 16.4
Enterprise Value (EV) 1 190.4 67.24 77.68 17.58 17.37
P/E ratio -19.7 x -4.98 x -5.04 x -1.48 x -1.1 x
Yield - - - - -
Capitalization / Revenue 268 x 14.7 x 6.93 x 0.91 x 0.65 x
EV / Revenue 248 x 13.3 x 6.73 x 0.86 x 0.69 x
EV / EBITDA -21,656,443 x -5,731,583 x -5,610,641 x -1,631,361 x -1,502,240 x
EV / FCF -40,333,619 x -3,194,920 x -10,789,199 x -3,275,034 x -4,927,928 x
FCF Yield -0% -0% -0% -0% -0%
Price to Book 12 x 1.55 x 1.87 x 0.45 x 0.55 x
Nbr of stocks (in thousands) 203,310 233,310 262,374 316,005 381,289
Reference price 2 1.010 0.3200 0.3050 0.0590 0.0430
Announcement Date 8/22/19 8/27/20 8/30/21 8/30/22 8/31/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.008576 0.767 5.062 11.54 20.52 25.09
EBITDA - -8.793 -11.73 -13.85 -10.77 -11.56
EBIT 1 -1.5 -8.796 -11.92 -14.93 -12.49 -13.32
Operating Margin -17,491.63% -1,146.81% -235.4% -129.37% -60.85% -53.1%
Earnings before Tax (EBT) 1 -1.497 -8.675 -14.77 -15.05 -12.12 -13.72
Net income 1 -1.497 -8.675 -14.77 -15.05 -12.12 -13.72
Net margin -17,458.82% -1,131.03% -291.74% -130.38% -59.08% -54.7%
EPS - -0.0511 -0.0642 -0.0605 -0.0399 -0.0391
Free Cash Flow - -4.721 -21.05 -7.2 -5.367 -3.526
FCF margin - -615.55% -415.75% -62.39% -26.15% -14.05%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/19/18 8/22/19 8/27/20 8/30/21 8/30/22 8/31/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 0.98
Net Cash position 1 2.5 14.9 7.42 2.34 1.07 -
Leverage (Debt/EBITDA) - - - - - -0.0846 x
Free Cash Flow - -4.72 -21 -7.2 -5.37 -3.53
ROE (net income / shareholders' equity) - -85.9% -45.4% -33.9% -28.8% -38.5%
ROA (Net income/ Total Assets) - -51% -20.5% -17.6% -14.1% -15.9%
Assets 1 - 17.03 71.94 85.7 85.81 86.45
Book Value Per Share 2 0.0200 0.0800 0.2100 0.1600 0.1300 0.0800
Cash Flow per Share 2 0.0100 0.0700 0.0400 0.0200 0.0200 0.0100
Capex - 1.06 9.93 1.79 0.85 1.47
Capex / Sales - 138.33% 196.25% 15.54% 4.14% 5.85%
Announcement Date 9/19/18 8/22/19 8/27/20 8/30/21 8/30/22 8/31/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALTHEA GROUP HOLDINGS LIMITED Stock Althea Group Holdings Limited
-23.08% 8.14M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AGH Stock
  4. Financials Althea Group Holdings Limited